(AZO) AutoZone - Ratings and Ratios
Automotive Parts, Accessories, Fluids, Tools, Software
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 21.5% |
| Value at Risk 5%th | 35.5% |
| Relative Tail Risk | 0.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.10 |
| Alpha | -6.54 |
| CAGR/Max DD | 0.40 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.470 |
| Beta | 0.141 |
| Beta Downside | -0.011 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.48% |
| Mean DD | 5.51% |
| Median DD | 4.28% |
Description: AZO AutoZone December 03, 2025
AutoZone, Inc. (NYSE: AZO) is a leading retailer and distributor of automotive replacement parts and accessories across the United States, Mexico, and Brazil. Its product portfolio spans new and remanufactured hard parts, maintenance items, and a broad range of non-automotive goods, sold through a network of over 6,600 stores and multiple e-commerce channels, including the ALLDATA diagnostic software platform and the Duralast private-label line.
In FY 2023 the company generated roughly $13.7 billion in revenue, delivering a 5.2% same-store sales increase and an operating margin near 15%, underscoring the resilience of the DIY automotive repair segment. Key economic drivers include rising vehicle-miles-travelled (VMT) as the U.S. fleet ages, and a modest inflation-adjusted price-elasticity that allows AutoZone to maintain pricing power while consumers defer dealership service. The sector benefits from a low-capex business model and strong cash conversion, which supports its ongoing share-repurchase program.
For a deeper, data-driven assessment of AZO’s valuation and risk profile, you may find the analyst notes on ValueRay worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.46b TTM) > 0 and > 6% of Revenue (6% = 1.16b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -1.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.11% (prev -7.90%; Δ 0.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 3.25b > Net Income 2.46b (YES >=105%, WARN >=100%) |
| Net Debt (11.76b) to EBITDA (4.18b) ratio: 2.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.1m) change vs 12m ago -1.54% (target <= -2.0% for YES) |
| Gross Margin 52.15% (prev 53.13%; Δ -0.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 103.9% (prev 106.4%; Δ -2.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.49 (EBITDA TTM 4.18b / Interest Expense TTM 474.5m) >= 6 (WARN >= 3) |
Altman Z'' 0.09
| (A) -0.07 = (Total Current Assets 8.44b - Total Current Liabilities 9.81b) / Total Assets 19.67b |
| (B) -0.18 = Retained Earnings (Balance) -3.45b / Total Assets 19.67b |
| (C) 0.19 = EBIT TTM 3.55b / Avg Total Assets 18.57b |
| (D) -0.16 = Book Value of Equity -3.71b / Total Liabilities 22.89b |
| Total Rating: 0.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.84
| 1. Piotroski 4.50pt |
| 2. FCF Yield 2.71% |
| 3. FCF Margin 9.62% |
| 4. Debt/Equity -3.73 |
| 5. Debt/Ebitda 2.81 |
| 6. ROIC - WACC (= 49.44)% |
| 7. RoE -65.38% |
| 8. Rev. Trend 42.24% |
| 9. EPS Trend 48.09% |
What is the price of AZO shares?
Over the past week, the price has changed by -4.53%, over one month by -13.86%, over three months by -22.27% and over the past year by -1.47%.
Is AZO a buy, sell or hold?
- Strong Buy: 17
- Buy: 6
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the AZO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4331.4 | 33.5% |
| Analysts Target Price | 4331.4 | 33.5% |
| ValueRay Target Price | 3207.2 | -1.2% |
AZO Fundamental Data Overview December 31, 2025
P/E Trailing = 24.0381
P/E Forward = 22.2717
P/S = 2.9456
P/B = 13.383
P/EG = 1.8112
Beta = 0.405
Revenue TTM = 19.29b USD
EBIT TTM = 3.55b USD
EBITDA TTM = 4.18b USD
Long Term Debt = 8.62b USD (from longTermDebt, last quarter)
Short Term Debt = 287.2m USD (from shortTermDebt, last quarter)
Debt = 12.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.76b USD (from netDebt column, last quarter)
Enterprise Value = 68.58b USD (56.81b + Debt 12.05b - CCE 287.6m)
Interest Coverage Ratio = 7.49 (Ebit TTM 3.55b / Interest Expense TTM 474.5m)
FCF Yield = 2.71% (FCF TTM 1.86b / Enterprise Value 68.58b)
FCF Margin = 9.62% (FCF TTM 1.86b / Revenue TTM 19.29b)
Net Margin = 12.78% (Net Income TTM 2.46b / Revenue TTM 19.29b)
Gross Margin = 52.15% ((Revenue TTM 19.29b - Cost of Revenue TTM 9.23b) / Revenue TTM)
Gross Margin QoQ = 50.97% (prev 51.52%)
Tobins Q-Ratio = 3.49 (Enterprise Value 68.58b / Total Assets 19.67b)
Interest Expense / Debt = 0.88% (Interest Expense 106.3m / Debt 12.05b)
Taxrate = 21.70% (147.1m / 677.9m)
NOPAT = 2.78b (EBIT 3.55b * (1 - 21.70%))
Current Ratio = 0.86 (Total Current Assets 8.44b / Total Current Liabilities 9.81b)
Debt / Equity = -3.73 (negative equity) (Debt 12.05b / totalStockholderEquity, last quarter -3.23b)
Debt / EBITDA = 2.81 (Net Debt 11.76b / EBITDA 4.18b)
Debt / FCF = 6.34 (Net Debt 11.76b / FCF TTM 1.86b)
Total Stockholder Equity = -3.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.53% (Net Income 2.46b / Total Assets 19.67b)
RoE = -65.38% (negative equity) (Net Income TTM 2.46b / Total Stockholder Equity -3.77b)
RoCE = 73.20% (EBIT 3.55b / Capital Employed (Equity -3.77b + L.T.Debt 8.62b))
RoIC = 54.95% (NOPAT 2.78b / Invested Capital 5.06b)
WACC = 5.51% (E(56.81b)/V(68.86b) * Re(6.53%) + D(12.05b)/V(68.86b) * Rd(0.88%) * (1-Tc(0.22)))
Discount Rate = 6.53% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.15%
[DCF Debug] Terminal Value 76.95% ; FCFE base≈1.87b ; Y1≈1.72b ; Y5≈1.53b
Fair Price DCF = 1666 (DCF Value 27.60b / Shares Outstanding 16.6m; 5y FCF grow -10.39% → 3.0% )
EPS Correlation: 48.09 | EPS CAGR: 9.22% | SUE: -2.51 | # QB: 0
Revenue Correlation: 42.24 | Revenue CAGR: 8.83% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-02-28): EPS=27.37 | Chg30d=-1.477 | Revisions Net=-18 | Analysts=24
EPS current Year (2026-08-31): EPS=147.09 | Chg30d=-4.600 | Revisions Net=-19 | Growth EPS=+1.5% | Growth Revenue=+8.6%
EPS next Year (2027-08-31): EPS=175.59 | Chg30d=-5.984 | Revisions Net=-14 | Growth EPS=+19.4% | Growth Revenue=+7.4%
Additional Sources for AZO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle